New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For SNTA;ESI;FLIR;LH;PCL;DNB From The Last 14 Days
Check below for free stories on SNTA;ESI;FLIR;LH;PCL;DNB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
10:01 EDTSNTASynta Pharmaceuticals strength a selling opportunity, says Stifel
Subscribe for More Information
09:07 EDTSNTASynta Pharmaceuticals data positive, says JMP Securities
JMP Securities believes that early top-line data indicates Synta's ganetespib plus current standard of care, low-dose Ara-C provide clinical benefit in high-risk elderly patients with newly diagnosed AML and MDS. The firm says the results increase its confidence in a positive GALAXY-2 outcome in NSCLC and broad applicability of ganetespib across a variety of tumor types. It keeps an Outperform rating on the stock.
July 21, 2014
16:32 EDTSNTASynta Pharmaceuticals advances ganetespib into Phase 3 extension of AML LI-1
Synta Pharmaceuticals announced the advancement of ganetespib into the Phase 3 extension of the AML LI-1 trial. AML LI-1 is a multicenter, randomized Phase 2/3 clinical study evaluating several novel treatment regimens, including the combination of ganetespib with low dose cytarabine, in newly diagnosed elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome who are not eligible for intensive chemotherapy. Ganetespib is a next-generation inhibitor of the chaperone protein Hsp90, which is critical for the activation and stability of numerous proteins that drive cancer growth and proliferation. Ganetespib has been studied in over 1000 patients to date. Advancement into the Phase 3 extension follows an interim analysis of results from 50 patients who received the ganetespib-cytarabine combination in the Phase 2 portion of the trial. The primary efficacy outcome in Phase 2 was rate of complete response. Per protocol, the Phase 3 extension will include an interim futility analysis and enroll approximately 200 patients in the ganetespib-cytarabine and the cytarabine alone arms, for a total of approximately 400 patients. The primary efficacy endpoint for the Phase 3 extension will include overall survival. The Company is currently in discussion with study investigators, and anticipates providing additional details, including the timing of study milestones, as they become formalized. The AML LI-1 trial is the first of three multicenter, randomized studies supported by the Leukemia & Lymphoma Research Fund and Cancer Research UK to include a ganetespib treatment arm. AML LI-1 is being conducted under the auspices of the UK’s National Cancer Research Institute Haematological Oncology Study Group, with investigators in Denmark, France, New Zealand, and the UK, and under the sponsorship of Cardiff University, UK. The other two studies, to be initiated later this year, are the AML-18 trial, evaluating ganetespib with standard DA in patients over 60 years old who can tolerate intensive chemotherapy, and the AML-19 trial, evaluating ganetespib in combination with conventional chemotherapy in younger patients with AML.
08:09 EDTLHLabCorp price target raised to $130 from $120 at Maxim
Subscribe for More Information
July 18, 2014
12:04 EDTLHLabCorp pullback a buying opportunity, says Maxim
Subscribe for More Information
11:25 EDTLHPiper awaits notable volume recovery to get more positive on LabCorp
Piper Jaffray views LabCorp's in-line quarter as positive and said restored TRICARE coverage may provide added upside, but the firm would like to see notable lab volume recovery and a pullback in the shares before becoming more positive on the stock. Piper raised its price target on the stock to $99 from $98 and maintains its Neutral rating on LabCorp.
10:03 EDTFLIROn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:43 EDTLHLabCorp raises FY14 adjusted EPS to $6.50-$6.75 from $6.40-$6.70
Subscribe for More Information
06:43 EDTLHLabCorp: Q2 sales increase due to test volume
Total test volume increased 5.3%, while revenue per requisition decreased 2.0% due to test and payer mix. Reports Q2 operating income $246.7M, operating cash flow $207.4M, free cash flow $159M
06:41 EDTLHLabCorp reports Q2 adjusted EPS $1.84, consensus $1.77
Subscribe for More Information
July 17, 2014
16:10 EDTFLIRFLIR Systems initiated with an Outperform at Oppenheimer
Target $40.
09:34 EDTLHLabCorp upgraded to Outperform from Market Perform at William Blair
Subscribe for More Information
July 15, 2014
09:59 EDTESIApollo Education discloses new Department of Education review
Subscribe for More Information
July 14, 2014
08:59 EDTLHLabCorp management to meet with Maxim
Field trip to company lab to be held in New Jersey on July 15 hosted by Maxim.
July 10, 2014
18:54 EDTPCLPlum Creek Timber MDF facility resumes full production
Plum Creek Timber announced that production resumed this week at its Medium Density Fiberboard facility in Columbia Falls, Mont. following a fire that occurred on June 10. The No. 2 production line, which makes between 1/10th- ˝-inch continuous-press fiberboard, restarted June 30 and the company began shipping product to customers. The No. 1 production line resumes full production this week. It produces up to 1 1/2–inch fiberboard. A mechanical failure occurred, causing the fire, which was contained by local fire and safety departments. All employees were safely evacuated and there were no reported injuries. Tom Ray, vice president, northwest resources and manufacturing, said both the fire response and facility repair efforts were outstanding examples of people working together safely to support common goals, “We are very thankful that all the local fire and safety departments rallied to protect the people working at the facility.” He said that Plum Creek will donate $15,000 to be shared by all the response units that helped fight the fire. “Their work is greatly appreciated and we hope these funds support the important work they provide every day to our community,” he said. While production ceased at the facility for about three weeks following the fire, the company continued to ship product to customers from existing inventory. The 183 employees who work at the facility never lost a day of work. All were reassigned to carry out a variety of tasks, including fire watch, cleanup, and repair. In late June, many helped bring production back on line, assisting with equipment testing to ensure it worked safely and met manufacturing standards. Resumption of normal production concludes a month-long recovery and repair process, which relied on the efforts of both employees and contractors. Damages to the plant are estimated in the $8M-10M range. All major repairs to the facility have been completed, including repairs to computer systems, duct work and upgrades to the fire suppression systems. Scaffolding remains visible on the exterior to the plant while the company replaces sheet metal but these activities will not affect plant production. Plum Creek operates Montana manufacturing facilities that produce lumber, plywood and MDF. These products are sold to construction, retail, industrial and other specialty markets.
July 9, 2014
10:02 EDTPCLOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Advanced Energy (AEIS) downgraded to Neutral from Buy at Dougherty... Apollo Global (APO) downgraded to Neutral from Buy at Citigroup... Artisan Partners (APAM) downgraded to Neutral from Buy at Citigroup... Autoliv (ALV) downgraded to Hold from Buy at Nordea... BNP Paribas (BNPQY) downgraded to Neutral from Overweight at JPMorgan... BP (BP) downgraded to Hold from Buy at Deutsche Bank... Carlyle Group (CG) downgraded to Neutral from Buy at Citigroup... Coach (COH) downgraded at Buckingham... Cummins (CMI) downgraded to Buy from Conviction Buy at Goldman... Garmin (GRMN) downgraded to Underperform from Sector Perform at Pacific Crest... Gigamon (GIMO) downgraded to Buy from Strong Buy at Needham... International Paper (IP) downgraded at RBC Capital... Louisiana-Pacific (LPX) downgraded at RBC Capital... Marvell (MRVL) downgraded to Underperform from Perform at Oppenheimer... McGraw Hill Financial (MHFI) downgraded to Market Perform at Raymond James... Moody's (MCO) downgraded to Market Perform from Outperform at Raymond James... Plum Creek Timber (PCL) downgraded at RBC Capital... Potash (POT) downgraded to Neutral from Overweight at JPMorgan... RGS Energy (RGSE) downgraded at Cowen... Taminco (TAM) downgraded to Neutral from Buy at Citigroup... Total (TOT) downgraded to Hold from Buy at Societe Generale... Unilever (UN) downgraded to Reduce from Neutral at Nomura... VMware (VMW) downgraded to Market Perform from Outperform at Wells Fargo... Vectren (VVC) downgraded to Hold from Buy at KeyBanc.
07:18 EDTPCLPlum Creek Timber downgraded at RBC Capital
Subscribe for More Information
06:11 EDTPCLPlum Creek Timber downgraded to Sector Perform from Outperform at RBC Capital

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use